|
Sign In to gain access to subscriptions and/or personal tools.
|
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
Gabriel Y Lai
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Tiffany L Gary
Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland; Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St. E6531, Baltimore, MD 21205, USA; tgary{at}jhsph.edu
Jon Tilburt
Shari Bolen
Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Charles Baffi
Cancer Prevention Fellowship Program, National Cancer Institute, Bethesda, Maryland, USA
Renee F Wilson
Evidence-based Practice Center, Johns Hopkins University, Baltimore, Maryland, USA, Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Mollie W Howerton
Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
M Chris Gibbons
Urban Health Institute, Johns Hopkins University, Baltimore, Maryland, USA; Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Teerath Peter Tanpitukpongse
Evidence-based Practice Center, Johns Hopkins University, Baltimore, Maryland, USA
Neil R Powe
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA; Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Eric B Bass
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Evidence-based Practice Center, Johns Hopkins University, Baltimore, Maryland, USA; Urban Health Institute, Johns Hopkins University, Baltimore, Maryland, USA
Jean G Ford
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Background Certain populations, including racial and ethnic minorities and older persons, have had a history of low participation in cancer-related trials, yet there has been little information reported on recruitment strategies tailored to improve their enrollment.
Methods We conducted a systematic literature review to examine the methods used to study recruitment of underrepresented populations into cancer prevention and treatment trials and examined the studies that compared the efficacy and/or effectiveness of different recruitment strategies. We performed an electronic search through multiple databases including PubMed and a hand search of 34 journals. Potential studies were pulled and underwent title, abstract, and article review by at least two investigators.
Results Fourteen articles examined recruitment of underrepresented populations into cancer trials and, of these, five compared efficacy or effectiveness of different strategies for recruitment of underrepresented populations into randomized or concurrent controlled trials. These five studies used various strategies but only three reported that specific recruitment strategies, such as media campaigns and churchbased project sessions, resulted in improvement in accrual to cancer trials.
Conclusion There is limited evidence for efficacious or effective strategies to recruit underrepresented populations in cancer-related trials. The available evidence cannot be generalized to these heterogeneous groups. Further study is needed on efficacious strategies for recruitment of underrepresented populations into cancerrelated trials.
References
- 1. National Institute of Health. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research–Amended, October, 2001 [cited October 1, 2004]. Available from: http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
- 2. Gordis L.Epidemiology, third edition Elsevier-Saunders, 2004.
- 3. Sateren WB, Trimble EL, Abrams J et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol, 2002; 20: 2109–2217.[Abstract/Free Full Text]
- 4. Lewis JH, Kilgore ML, Goldman DP et al.Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383–1189.[Abstract/Free Full Text]
- 5. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004; 291: 2720–2226.[Abstract/Free Full Text]
- 6. Jemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004; 101: 3–27.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 7. Singh GK, Miller BA, Hankey BF, Edwards BK.Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival 1975–1999.
- 8. U.S. Cancer Statistics Working Group.United States Cancer Statistics: 1999–2001 Incidence and Mortality Web-based Report Version. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute.
- 9. Ward E, Jemal A, Cokkinides V et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004; 54: 78–93.[Abstract/Free Full Text]
- 10. National Cancer Institute. The Surveillance, Epidemiology, and End Results (SEER) program. Incidence: all cancer sites [cited March 1, 2005]. Available from http://seer.cancer.gov/faststats/html/inc_all.html.
- 11. National Cancer Institute. The Surveillance, Epidemiology, and End Results (SEER) program. Mortality: all cancer sites [cited March 1, 2005]. Available from http://seer.cancer.gov/faststats/html/mor_all.html.
- 12. Institute of Medicine.The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academy Press, 1999.
- 13. Ford JG, Howerton MW, Bolen S et al. Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment (Summary). 2005; 122: 1–11.
- 14. Advani AS, Atkeson B, Brown CL et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003; 97: 1499–1506.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 15. Berman BA, Grosser SC, Gritz ER. Recruitment to a school-based adult smoking-cessation program: do gender and race/ethnicity make a difference? J Cancer Educ 1998; 13: 220–225.[Medline]
[Order article via Infotrieve]
- 16. Brewster WR, Anton-Culver H, Ziogas A et al.Recruitment strategies for cervical cancer prevention study. Gynecol Oncol 2002; 85: 250–254.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 17. Ford M, Havstad S, Davis SD. A randomized trial of recruitment methods for older African-American men in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Clinical Trials 2004; 1: 343–351.
- 18. Kaluzny A, Brawley O, Garson-Angert D et al.Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 1993; 85: 1945–1150.[Abstract/Free Full Text]
- 19. Linnan LA, Emmons KM, Klar N, Fava JL, LaForge RG, Abrams DB. Challenges to improving the impact of worksite cancer prevention programs: comparing reach, enrollment, and attrition using active versus passive recruitment strategies. Ann Behav Med 2002; 24: 157–166.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 20. Maurer LH, Davis T, Hammond S, Smith E, West P, Doolittle M. Clinical trials in a rural population: professional education aspects. J Cancer Educ 2001; 16: 89–92.[Web of Science][Medline]
[Order article via Infotrieve]
- 21. Moinpour CM, Atkinson JO, Thomas SM et al.Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 2000; 10(Suppl.): S85–S91.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 22. Paskett ED, Cooper MR, DeGraffinreid CR, Spurr CL, Dolecek TA. Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience. N C Med J 1995; 56: 283–286.[Medline]
[Order article via Infotrieve]
- 23. Paskett ED, Cooper MR, Stark N et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract2002; 10: 28–35.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- 24. Randall-David B, Stark N, Gierisch J, Torti F.‘What do they know about it/’ How the North Carolina public views cancer clinical trials: implications for primary care doctors. N C Med J 2001; 62: 281–285.[Medline]
[Order article via Infotrieve]
- 25. Sears SR, Stanton AL, Kwan L et al. Recruitment and retention challenges in breast cancer survivorship research: results from a multisite, randomized intervention trial in women with early stage breast cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 1087–1190.[Abstract/Free Full Text]
- 26. Thornquist MD, Patrick DL, Omenn GS.Participation and adherence among older men and women recruited to the Beta-Carotene and Retinol Efficacy trial (CARET). Gerontologist 1991; 31: 593–597.[Abstract/Free Full Text]
- 27. Zhu K, Hunter S, Bernard LJ, Payne-Wilks K, Roland CL, Levine RS. Recruiting elderly African American women in cancer prevention and control studies: a multifaceted approach and its effectiveness. J Natl Med Assoc 2000; 92: 169–175.[Medline]
[Order article via Infotrieve]
- 28. Kimmick GG, Peterson BL, Kornblith AB,et al.Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol 2005; 23: 2201–2207.[Abstract/Free Full Text]
Clinical Trials, Vol. 3, No. 2,
133-141 (2006)
DOI: 10.1191/1740774506cn143oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Gutierrez-Luna, A. Angeles-Llerenas, V. J Wirtz, A. A. Del Rio, L. Zamilpa-Mejia, C. Aranda-Flores, J. L. Viramontes, and E. Lazcano-Ponce
Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico
Clinical Trials,
August 1, 2009;
6(4):
365 - 372.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. M Frierson, D. M Williams, S. Dunsiger, B. A Lewis, J. A Whiteley, A. E Albrecht, J. M Jakicic, S. M Horowitz, and B. H Marcus
Recruitment of a racially and ethnically diverse sample into a physical activity efficacy trial
Clinical Trials,
October 1, 2008;
5(5):
504 - 516.
[Abstract]
[PDF]
|
|
|
|
|
